More on Athersys (ATHX): Q1 misses on both EPS and revenue as total sales reflected a $2.4M...

|By:, SA News Editor

More on Athersys (ATHX): Q1 misses on both EPS and revenue as total sales reflected a $2.4M decrease in Pfizer contract revenues. Net losses more than doubled over the period, as fair value of warrant liabilities resulted in an expense of $2.6M due to the re-pricing and increases in share price. Shares -3.3% AH.